Welcome to our presentation about the proper intramuscular injection technique required for the administration of Nebido®

Full presentation

PP-NEB-GB-0384

NEBIDO Profile/ Indication/ Contra-Indication

PP-NEB-GB-0384

Preparation and handling
Preparation & Vial Handling

PP-NEB-GB-0384

Injection site
Preparation of Injection/ Identification of injection site

PP-NEB-GB-0384

Injection technique

PP-NEB-GB-0384

Monitoring
Monitoring (PSA, Haematocrit, etc.)

PP-NEB-GB-0384

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk.

Adverse events should also be reported to Bayer plc, Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.

If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc, Email: qualitycomplaints@bayer.com

For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.